1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Fluoride Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dental Fluoride Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Advantages and disadvantages of dental fluoride treatment
5.2. Key Industry Events
5.3. Brand Analysis by product categories
5.4. Regulatory Scenario
5.5. COVID-19 Pandemic Impact on Industry
6. Global Dental Fluoride Treatment Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Topical
6.3.1.1. Toothpaste
6.3.1.2. Varnish
6.3.1.3. Gels/Foams
6.3.1.4. Mouthrinse
6.3.1.5. Others
6.3.2. Systemic
6.3.2.1. Water Fluoridation
6.3.2.2. Dietary Fluoride Supplements
6.4. Market Attractiveness Analysis, by Product Type
7. Global Dental Fluoride Treatment Market Analysis and Forecast, by Age Group
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Age Group, 2017–2031
7.3.1. Adults
7.3.2. Children
7.4. Market Attractiveness Analysis, by Age Group
8. Global Dental Fluoride Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Professional-use
8.3.1.1. Hospitals
8.3.1.2. Dental Clinics
8.3.2. Personal-use
8.4. Market Attractiveness Analysis, by End-user
9. Global Dental Fluoride Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Dental Fluoride Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Topical
10.2.1.1. Toothpaste
10.2.1.2. Varnish
10.2.1.3. Gels/Foams
10.2.1.4. Mouthrinse
10.2.1.5. Others
10.2.2. Systemic
10.2.2.1. Water Fluoridation
10.2.2.2. Dietary Fluoride Supplements
10.3. Market Value Forecast, by Age Group, 2017–2031
10.3.1. Adults
10.3.2. Children
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Professional-use
10.4.1.1. Hospitals
10.4.1.2. Dental Clinics
10.4.2. Personal-use
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Age Group
10.6.3. By End-user
10.6.4. By Country
11. Europe Dental Fluoride Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Topical
11.2.1.1. Toothpaste
11.2.1.2. Varnish
11.2.1.3. Gels/Foams
11.2.1.4. Mouthrinse
11.2.1.5. Others
11.2.2. Systemic
11.2.2.1. Water Fluoridation
11.2.2.2. Dietary Fluoride Supplements
11.3. Market Value Forecast, by Age Group, 2017–2031
11.3.1. Adults
11.3.2. Children
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Professional-use
11.4.1.1. Hospitals
11.4.1.2. Dental Clinics
11.4.2. Personal-use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Age Group
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Dental Fluoride Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Topical
12.2.1.1. Toothpaste
12.2.1.2. Varnish
12.2.1.3. Gels/Foams
12.2.1.4. Mouthrinse
12.2.1.5. Others
12.2.2. Systemic
12.2.2.1. Water Fluoridation
12.2.2.2. Dietary Fluoride Supplements
12.3. Market Value Forecast, by Age Group, 2017–2031
12.3.1. Adults
12.3.2. Children
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Professional-use
12.4.1.1. Hospitals
12.4.1.2. Dental Clinics
12.4.2. Personal-use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Age Group
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Dental Fluoride Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Topical
13.2.1.1. Toothpaste
13.2.1.2. Varnish
13.2.1.3. Gels/Foams
13.2.1.4. Mouthrinse
13.2.1.5. Others
13.2.2. Systemic
13.2.2.1. Water Fluoridation
13.2.2.2. Dietary Fluoride Supplements
13.3. Market Value Forecast, by Age Group, 2017–2031
13.3.1. Adults
13.3.2. Children
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Professional-use
13.4.1.1. Hospitals
13.4.1.2. Dental Clinics
13.4.2. Personal-use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Age Group
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Fluoride Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Topical
14.2.1.1. Toothpaste
14.2.1.2. Varnish
14.2.1.3. Gels/Foams
14.2.1.4. Mouthrinse
14.2.1.5. Others
14.2.2. Systemic
14.2.2.1. Water Fluoridation
14.2.2.2. Dietary Fluoride Supplements
14.3. Market Value Forecast, by Age Group, 2017–2031
14.3.1. Adults
14.3.2. Children
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Professional-use
14.4.1.1. Hospitals
14.4.1.2. Dental Clinics
14.4.2. Personal-use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Age Group
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis. by Company, 2022
15.3. Company Profiles
15.3.1. Colgate-Palmolive Company
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Koninklijke Philips N.V.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Dentsply Sirona
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. 3M
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Dürr Dental
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Dmg Dental
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Method Pharmaceuticals, LLC
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. The Nature Masons
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Young Dental Manufacturing I LLC
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Ivoclar Vivadent
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Simplut Company
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/